Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Markham Valley Ventures is a private venture capital firm that specializes in early-stage investments within the life sciences and biotechnology sectors. The firm is led by Dr. Michael J. Ross, a prominent biotech executive and investor known for his tenure at Genentech and SV Health Investors. Markham Valley Ventures focuses on identifying and supporting startups with the potential to transform patient care through innovative therapeutics and medical devices. Beyond providing financial support, the firm offers strategic mentorship and operational expertise to help early-stage companies achieve key developmental milestones. Its portfolio includes a variety of biopharmaceutical companies, reflecting a broad interest in cutting-edge medical science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Markham Valley Ventures.